These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14492088)

  • 21. [Contribution to the electroencephalographic study of phenothiazine neuroleptic therapy].
    SIFFERMANN A; SPIELMANN JP; PERRIN J
    Med Exp Int J Exp Med; 1961; 5():391-5. PubMed ID: 13912699
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the pharmacological properties of 3-cyano-10-(3-dimethylamino-2-methylpropyl)-phenothiazine or cyamepromazine (R.P. 7.204)].
    JULOU L; DUCROT R; FOURNEL J; LEAUO ; BARDONE MC; MYON J
    C R Seances Soc Biol Fil; 1961; 155():1029-34. PubMed ID: 14452776
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of a new phenothiazine derivative (U-5641) on renal excretion of water and electrolytes.
    PONTIDAS E; MILLS LC
    Antibiotic Med Clin Ther (New York); 1959 Dec; 6():715-7. PubMed ID: 14434038
    [No Abstract]   [Full Text] [Related]  

  • 24. The action of a phenothiazine derivative on enzymes of the pentose phosphate pathway.
    CARVER MJ; MARKS JD; ROESKY N
    Experientia; 1961 Jul; 17():315-6. PubMed ID: 13691208
    [No Abstract]   [Full Text] [Related]  

  • 25. [3-(1-methylsulfonyl-4-piperazino)-propyl] phenothiazine (R.P. 9.260)].
    LAMBERT PA; COURVOISIER S; JULOU L
    Psychopharmacologia; 1961; 2():209-13. PubMed ID: 13758459
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship of relative inhibitor potency to magnitude of challenge. I. Phenothiazine suppression of pecking syndromes of varying intensity.
    BURKMAN AM
    Arch Int Pharmacodyn Ther; 1962 Jun; 137():404-9. PubMed ID: 13874905
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of crystallized D-glyceraldehyde-3-phosphate dehydrogenase activity by phenothiazine and aminoketone].
    WOLLEMANN M; ELODI P
    Biochem Pharmacol; 1961 Jun; 6():228-32. PubMed ID: 13786410
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental catatonia induced by neuroleptic drugs. I. Action of phenothiazine derivatives].
    ALEMA G; GIANNIOTTI G; ROSADINI G
    Boll Soc Ital Biol Sper; 1961 Oct; 37():1037-40. PubMed ID: 13860287
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of 5-HT on the evolution of paw edema in normal or adrenalectomized rats].
    FRANCHIMONT P; LECOMTE J; VAN CAUWENBERGE H
    C R Seances Soc Biol Fil; 1962; 156():400-2. PubMed ID: 13894485
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on experimental shock; effects of vasopressor amines and phenothiazine derivatives.
    BRUNSON JG; KALINA RE; ECKMAN PL
    Am J Pathol; 1959; 35(6):1149-67. PubMed ID: 13805392
    [No Abstract]   [Full Text] [Related]  

  • 31. [The phenothiazines].
    CHINI F
    Minerva Farm; 1960 May; 9():75-6. PubMed ID: 13809880
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology and use of phenothiazine derivatives].
    WESTERINK D
    Pharm Weekbl; 1956 Feb; 91(4):113-25. PubMed ID: 13310219
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contribution to the in vitro effect of phenothiazines on the activity of ribonuclease].
    KUSCH T; HEINRICH I; HOFMANN H
    Acta Biol Med Ger; 1962; 8():439-41. PubMed ID: 14460872
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butvrophenone.
    JANSSEN PA; NIEMEGEERS CJ
    Arzneimittelforschung; 1959 Dec; 9():765-7. PubMed ID: 14406751
    [No Abstract]   [Full Text] [Related]  

  • 35. Relative potencies of some phenothiazines as pecking syndrome inhibitors.
    BURKMAN AM
    J Pharm Sci; 1961 Sep; 50():771-3. PubMed ID: 13689104
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of N-piperidinoalkyl-phenothiazine].
    NIESCHULZ O; POPENDIKER K
    Arzneimittelforschung; 1955 Aug; 5(8):458-60. PubMed ID: 13276251
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the significance of various pharmacodynamic properties of phenothiazine derivatives in relation to their clinical efficacy].
    TAESCHLER M; FANCHAMPS A; CERLETTI A
    Psychiatr Neurol (Basel); 1960; 139():85-104. PubMed ID: 13836566
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the effect of neuroplegic substances on the chemoreception].
    VIKHLIAEV IuI
    Uch Zap Inst Farmakol Khimioter AMN SSSR; 1960; 2():114-20. PubMed ID: 13925911
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of phenothiazine derivatives on allergic manifestations].
    SPICAK V; BELSKA M
    Cesk Pediatr; 1960 Jun; 15():648-50. PubMed ID: 13833301
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and anti-inflammatory activity of some heterocyclic derivatives of phenothiazine.
    Sharma S; Srivastava VK; Kumar A
    Pharmazie; 2005 Jan; 60(1):18-22. PubMed ID: 15700774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.